March 5, 2024
Shionogi on March 5 obtained an official stamp of approval in Japan for its COVID-19 treatment Xocova (ensitrelvir), which had been granted an emergency nod back in 2022. It is the first antiviral therapy for COVID-19 to receive standard approval...read more